How Trump tariffs could affect weight loss drugs
qz.com › novo-nordisk-ozempic-wegovy-tariffs-1851755894
This story seems to be about:
This story seems to be about:
Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed by U.S. President Donald Trump could affect its business.